2012•New England Journal of MedicineOpen access
Hereditary Systemic Amyloidosis Due to Asp76Asn Variant β2-Microglobulin
Sophie Valleix, Julian D. Gillmore, Frank Bridoux, P. Patrizia Mangione, Ahmet Doǧan, Brigitte Nédelec, Mathieu Boimard, Guy Touchard, Jean‐Michel Goujon, Corinne Lacombe, Pierre Lozeron, David Adams, Catherine Lacroix, Thierry Maisonobe, Violaine Planté‐Bordeneuve, Julie A. Vrana, Jason D. Theis, Sofia Giorgetti, Riccardo Porcari, Stéfano Ricagno, Martino Bolognesi, Monica Stoppini, Marc Delpech, Mark B. Pepys, Philip N. Hawkins, Vittorio Bellotti
Abstract
We describe a kindred with slowly progressive gastrointestinal symptoms and autonomic neuropathy caused by autosomal dominant, hereditary systemic amyloidosis. The amyloid consists of Asp76Asn variant β(2)-microglobulin. Unlike patients with dialysis-related amyloidosis caused by sustained high plasma concentrations of wild-type β(2)-microglobulin, the affected members of this kindred had normal renal function and normal circulating β(2)-microglobulin values. The Asp76Asn β(2)-microglobulin variant was thermodynamically unstable and remarkably fibrillogenic in vitro under physiological conditions. Previous studies of β(2)-microglobulin aggregation have not shown such amyloidogenicity for single-residue substitutions. Comprehensive biophysical characterization of the β(2)-microglobulin variant, including its 1.40-Å, three-dimensional structure, should allow further elucidation of fibrillogenesis and protein misfolding.